ANTHRAX
Anthrivig™
(Human Anthrax Immunoglobulin)
Therapeutic Candidate
Anthrivig™ (Human Anthrax Immunoglobulin) is being studied for use against symptomatic anthrax infection. It is derived from pooled sera of humans previously vaccinated with BioThrax® (Anthrax Vaccine Adsorbed) and contains human polyclonal antibodies.
Completed Clinical Trials LEARN MORE